Once-a-Week Ablative Radiotherapy as Replacement of Prolonged Fractionation in Frail Patients: Feasibility and Toxicity Results
This once-weekly hypofractionated radiotherapy regimen demonstrated feasibility, good tolerance, and promising tumor response in frail and elderly patients. Although limited by a small sample size, the approach offers a practical alternative for patients unable to undergo conventional daily radiotherapy. Further studies on larger cohorts are required to validate these findings.
Authors
- Flavio Giannelli
- Giorgia Timon (ORCID: https://orcid.org/0000-0002-1555-0940)
- Gianmario Sambuceti (ORCID: https://orcid.org/0000-0003-2979-6500)
- G. Vidano
- Matteo Bauckneht (ORCID: https://orcid.org/0000-0002-1937-9116)
- Francesco Lanfranchi (ORCID: https://orcid.org/0000-0002-6043-9627)
- Liliana Belgioia (ORCID: https://orcid.org/0000-0003-0508-6344)
- Camilla Satragno (ORCID: https://orcid.org/0000-0003-2865-5845)
- Alberto Tagliafico (ORCID: https://orcid.org/0000-0003-1736-0697)
- Gladys Blandino
- Michela Marcenaro
- Federica Picichè
- Alessandra Fozza
Institutions
- Ospedale Policlinico San Martino (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Cancer Investigation
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1080/07357907.2024.2425729
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00